Business Context and Reporting Period
Company: Rockwell Medical, Inc. (RMTI)
Filing Type: Form 8-K (Current Report)
Report Date: August 13, 2026
Reporting Period: Quarter ended June 30, 2026
Business Context: The registrant filed this report to announce financial results for the second quarter of fiscal year 2026. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain specific numerical data. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release regarding Q2 2026 results but does not include the text of the commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K filing.
Unusual Items: No unusual items are described in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 13, 2026) for actual revenue, earnings, and cash flow figures.
- Verify the specific details of the financial results for the quarter ended June 30, 2026, as they are not embedded in the 8-K text.
- Check for any forward-looking statements or updated guidance within the referenced press release.
- Confirm the trading status of Common Stock (RMTI) on the Nasdaq Capital Market.